Highlights
15th International Congress on Catalysis 2012
Munich/Germany
01.07.2012
- 06.07.2012
30. DECHEMA-Jahrestagung der Biotechnologen und ProcessNet-Jahrestagung 2012
Kongresszentrum, Karlsruhe
10.09.2012
- 13.09.2012
Programme
|
Monday, 5 November 2007
|
|
| 18:00 | Get-Together |
|
20:00 |
EVENING LECTURE Novel binding proteins: from protein design to therapeutic applications Andreas Plückthun, University of Zurich/CH |
| Tuesday, 6 November 2007 | |
| 8:00 | Breakfast |
|
9:00 |
Welcome and Opening Ulrich Behrendt, Roche Diagnostics GmbH, Penzberg/D and Chair of the Association of German Biotechnology Companies (VBU) |
|
9:15 |
KEYNOTE LECTURE
High titer cultivations: opportunities, challenges and potential solutions Dana C. Andersen, Genentech Inc., San Francisco, CA/USA |
| 10:00 |
Coffee Break |
| Session 1: First steps and alternatives | |
|
10:30 |
Capturing products from high titer cell culture processes: the capacity and throughput challenge?
Jörg Thömmes, Biogen Idec, San Diego, CA/USA |
|
11:00 |
Development of industrial protein crystallization processes Jörg Peters, Bayer HealthCare AG, Wuppertal/D |
|
11:30 |
High gradient magnetic separations – applicability and scalability for DsP
Matthias Franzreb, Forschungszentrum Karlsruhe GmbH/D |
|
12:00 |
Novel continuous extraction strategies using aqueous two-phase systems
Ian A. Sutherland, Brunel University, Uxbridge/UK |
|
12:30 |
Lunch |
| Session 2: Accelerating Bioprocess Development | |
|
14:00 |
Combining thermodynamics and chip technologies for process development
(Working title) Luuk van der Wielen, Delft University of Technology/NL |
|
14:30 |
High throughput process evaluation & early stage purification process development
Jon Coffman, M. Switzer, J. Booth, D. Wensel, B. Kelley, Wyeth-BioPharma, Andover, MA/USA |
|
15:00 |
Combining Hts and mathematic modelling in process development and control
Arne Staby, Novo Nordisk A/S, Gentofte/DK |
|
15:30 |
Model-based methods for process development, control and validation – applications on preparative chromatography Bernt Nilsson, Lund University/S |
| 16:00 | Coffee Break |
| Session 3: Inclusion Body Refolding | |
|
16:30 |
Protein aggregate formation in vivo Ario de Marco, Consortium for Genomic Technologies (COGENTECH), Milan/I |
| 17:00 |
Inclusion body refolding Rainer Rudolph, University of Halle-Wittenberg/D |
|
17:30 |
Large scale purification of biopharmaceuticals Klaus Graumann, Sandoz GmbH, Kundl/A |
| 18:00 | End of lectures of the 1st day |
| 18:15 | Transfer to Monastery Andechs on the Holy Mountain above the Lake Ammersee |
| 19:00 | Conference Dinner and beer tasting at monastery andechs |
| 23:00 | Transfer back to Schloss Tutzing |
| Wednesday, 7 November 2007 | |
| 8:45 | Welcome |
| Session 4: Single Use Concepts | |
|
9:00 |
Single use resins for bioseparation: manufacturing reality or just dream?
Reza Arshady, Citus Ltd, London/UK |
|
9:30 |
Disposable production – where do we stand?
Uwe Gottschalk, Sartorius Stedim Biotech, Göttingen/D |
|
10:00 |
Mab manufacturing: downstream processes for flexible manufacturing in multi-product scenarios
Günter Jagschies, GE Healthcare, Uppsala/S |
| 10:30 | Coffee Break |
| Session 5: Depletion of critical contaminants – Old workhorses and new concepts | |
|
11:00 |
Virus safety in pharma biotech development downstream processing
Stefan Hepbildikler, Roche Diagnostics GmbH, Penzberg/D |
|
11:30 |
Alternative routes for virus clearance and safety
Andrea Buchacher, G. Iberer, M. Karlovits, G. Gruber, M. Stadler, Octapharma Pharmazeutika ProduktionsGmbH, Vienna/A; C. Kannicht, Octapharma GmbH, Berlin/D; L. Biesert, Octapharma GmbH, Frankfurt/D; J. Römisch, Octapharma Pharmazeutika ProduktionsGmbH, Vienna/A |
|
12:00 |
Membranes in virus clearance
Oliver Triebsch, Pall GmbH, Dreieich/D |
|
12:30 |
KEYNOTE LECTURE Future challenges in viruses and viral vaccines purification Charles Lutsch, Sanofi Pasteur Inc., Swiftwater, PA/USA |
|
13:15 |
End of symposium: closing remarks Ulrich Behrendt, Roche Diagnostics GmbH, Penzberg/D and Chair of the Association of German Biotechnology Companies (VBU) |
| Additional programme with registration : | |
| 13:30 | Excursion to Roche Diagnostics GmbH, Penzberg/D |
| 14:15 | Arrival at Roche Diagnostics GmbH, Penzberg/D |
| 14:30 | Welcome |
| 15:00 | Roche visit and site tour |
| 16:30 | End of Roche visit and transfer to main station Munich |
| 18.30 | approx. arrival at main station Munich |